Advertisement
Bezlotoxumab (Zinplava) is effective in reducing the risk of recurrent Clostridium difficile infection

Bezlotoxumab Promising Against Recurrent Clostridium difficile

0
Medication cuts risk of recurrent C. difficile infections by 40 percent
Anxiety and depression may increase the risk of death from certain cancers

Anxiety, Depression May Up Mortality Risk for Some Cancers

0
Higher death rates seen for colorectal, esophageal, pancreatic, and prostate cancers, leukemia
The "opt out" rule

‘Opt Out’ Doesn’t Increase Access to Anesthesia Care

0
No increase in number of patients traveling outside home zip code, except for total hip arthroplasty
Young and middle-aged colon cancer patients may be getting chemotherapy more often than is warranted

Chemo May Be Overused in Younger Patients With Colon CA

0
Researchers find treatment often isn't beneficial

ASCO Gastrointestinal Cancers Symposium, Jan. 19-21

0
The 2017 Gastrointestinal Cancers Symposium The American Society of Clinical Oncology's 13th annual Gastrointestinal Cancers Symposium was held from Jan. 19 to 21...
Patients with type 1 diabetes exhibit inflammation in the digestive tract and gut bacteria in a pattern that differs from individuals who do not have diabetes or those who have celiac disease

Type 1 Diabetes Tied to Gut Inflammation, Microbiota

0
Type 1 diabetes patients exhibit different and distinct inflammation and gut microbiota
The most important concepts of obesity prevention and treatment are not adequately represented on the U.S. Medical Licensing Examination Step examinations

Obesity Underrepresented in Medical Licensing Exams

0
Exam items primarily address diagnosis and treatment of obesity-related comorbid conditions
Trulance has been approved by the U.S. Food and Drug Administration to treat persistent idiopathic constipation in adults.

FDA Approves Trulance for Chronic Idiopathic Constipation

0
Drug designed to stimulate secretion of intestinal fluid
For patients undergoing colorectal cancer surgery

CpG Island Methylator Phenotype Prognostic After CRC Surgery

0
CIMP-high is significant prognostic factor in multivariate analysis for patients after CRC resection
Just a half hour a day of moderate physical activity could improve survival odds for patients with metastatic colorectal cancer

ASCO: Moderate Activity Tied to Longer Survival in Advanced CRC

0
Patients only appeared to derive benefit from moderate -- not vigorous -- activity